Vertex Pharmaceuticals Incorporated (FRA:VX1)
Germany · Delayed Price · Currency is EUR 392.40
-6.75 (-1.69%)
At close: Jul 21, 2025, 10:00 PM CET
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €100.49 billion as of July 21, 2025. Its market cap has decreased by -11.75% in one year.
Market Cap
100.49B
Enterprise Value
92.20B
Revenue
10.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
€392.40
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 100.49B, an increase of 135,911.92%. That is a compound annual growth rate of 23.64%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 308.04B |
| Siemens Aktiengesellschaft | 174.51B |
| Deutsche Telekom AG | 148.03B |
| Allianz SE | 132.19B |
| Rheinmetall AG | 84.01B |
| Siemens Energy AG | 74.29B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 74.27B |
| Siemens Healthineers AG | 51.39B |